Asset Dedication LLC’s ImmunityBio IBRX Stock Holding History

Asset Dedication LLC’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-13,227	Closed	-$49K	–	614
2018 Q3	$49K	Hold	13,227	–	–	0.02%	265
2018 Q2	$40K	Hold	13,227	–	–	0.01%	294
2018 Q1	$51K	Hold	13,227	–	–	0.03%	233
2017 Q4	$59K	Hold	13,227	–	–	0.02%	227
2017 Q3	$72K	Hold	13,227	–	–	0.03%	177
2017 Q2	$100K	Hold	13,227	–	–	0.05%	165
2017 Q1	$47K	Hold	13,227	–	–	0.03%	212
2016 Q4	$76K	Hold	13,227	–	–	0.04%	174
2016 Q3	$103K	Hold	13,227	–	–	0.07%	152
2016 Q2	$82K	Buy	+13,227	New	+$103K	0.06%	160

Other funds holding IBRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Horizon Kinetics New York $3.06B AUM 5.37% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Asset Dedication LLC's IBRX Position: Q4 2018 in Review

Asset Dedication LLC sold out of ImmunityBio (IBRX) in Q4 2018, closing a stake of 13,227 shares — an estimated $49K sold.

Asset Dedication LLC first reported a position in IBRX in Q2 2016 and held it in 10 quarters. The position peaked at $103K in Q3 2016. 61 funds tracked by Wall St. Rank hold IBRX as of Q4 2018.

Asset Dedication LLC reported no remaining ImmunityBio position as of Q4 2018 after selling out during the quarter.
Asset Dedication LLC sold 13,227 ImmunityBio shares in Q4 2018, an estimated $49K.
Asset Dedication LLC first reported a position in ImmunityBio in Q2 2016 and held it in 10 quarters.
Asset Dedication LLC's ImmunityBio position peaked at $103K in Q3 2016.
61 funds tracked by Wall St. Rank held ImmunityBio as of Q4 2018.

Based on Asset Dedication LLC's 13F filing for Q4 2018, filed 12 Feb 2019.